𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin

✍ Scribed by Noshir A. Dacosta; Mae B. Hultin

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
171 KB
Volume
36
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anemia associated with advanced prostati
Anemia associated with advanced prostatic adenocarcinoma: Effects of recombinant human erythropoietin
✍ Beshara, Soheir; Letocha, Henry; Linde, TorbjΓΆrn; WikstrΓΆm, BjΓΆrn; Sandhagen, Bo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

## BACKGROUND AND METHODS. Nine patients with hormone-refractory metastatic prostatic adenocarcinoma and anemia were treated with recombinant human erythropoietin (rHuEpo) at a median dose of 150 U/kg BW 3 times a week subcutaneously. Baseline hemoglobin (Hb) ranged from 70 to 116 g/L, and the stu

Effect of recombinant human erythropoiet
Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: Association with early improvement in platelet function
✍ TΓ ssies, Dolors; Reverter, Joan Carles; Cases, Aleix; Calls, Jordi; Escolar, Gin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

Recombinant human erythropoietin improves platelet function in uremia through the correction of anemia, but this effect can be seen also before the hematocrit rise. We studied 12 hemodialyzed patients (seven men, five women) who received recombinant human erythropoietin (40 IU kg -1 i.v., three time